Shots: Kite will receive a one-time upfront to purchase Kite’s individualized solid tumor neoantigen TCR discovery platform, R&D & clinical manufacturing facility in Gaithersburg. The Transaction is expected to be […]readmore
Tags : Manufacturing Facility
Shots: MD Anderson signs an asset purchase agreement with Bellicum to acquire its 60,000-square-foot facility in Houston including its technical operation, quality staff, manufacturing, office and laboratory space for $15M. […]readmore
Shots: Sanofi signs a business transfer agreement with Zentiva to sell its manufacturing facility in Ankleshwar, India. In H1’19, Zentiva enhanced its network with the acquisition of Solacium in Romania […]readmore
Shots: Biocon has received EMA’s certificate of GMP compliance from European inspection authority, Health Products Regulatory Authority (Ireland) and expand its capacities multi-fold with the new large-scale devices facility to […]readmore
Shots: Catalent to purchase BMS’ oral solid, biologics, and sterile product manufacturing and packaging facility and will continue to manufacture BMS’s current product portfolio at the site, providing facilities in […]readmore
Shots: Thermo Fisher acquires a manufacturing facility in Ireland from GSK for ~$100M cash to develop & commercialize APIs for multiple diseases including childhood cancer, depression and Parkinson’s. The transaction […]readmore
Shots: REGENXBIO plans to construct a cGMP manufacturing facility in Rockville, Maryland to produce gene therapy vectors based on NAV technology at scales up to 2,000L using its platform suspension […]readmore
Shots: Eli Lilly to receive $75M upfront & $300M on the completion of transaction. Eddingpharm to get exclusive rights for Lilly’s two antibiotics, Ceclor and Vancocin and a manufacturing facility […]readmore
Shots: AveXis, a Novartis company purchases gene therapy manufacturing unit in Longmont, an addition to Durham facility of $115M investment, offering positions for 150 employees previously working at the site […]readmore